U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07070375) titled 'Pharmacokinetics and Safety of HRS-8427 in Healthy Volunteers and in Patients With Impaired Renal Function' on July 08.
Brief Summary: This study evaluated the pharmacokinetic profile, safety, and tolerability of HRS-8427 injection in subjects with mild, moderate, severe, or end-stage renal disease (ESRD) requiring dialysis, using subjects with normal renal function as controls, to inform clinical dosing in patients with renal impairment.
Study Start Date: April 19, 2023
Study Type: INTERVENTIONAL
Condition:
Gram-negative Bacterial Infections
Intervention:
DRUG: HRS-8427
HRS-8427
Recruitment Status: COMPLETED
Sponsor: Jiang...